{
  "meta": {
    "data_length": 1,
    "message": "Proposition id 341 retrieved successfully",
    "request_url": "http://api.moalmanac.org/propositions?proposition_id=341",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.013724,
    "timestamp_received": "2026-06-08T12:58:39.298483+00:00Z",
    "timestamp_returned": "2026-06-08T12:58:39.312207+00:00Z",
    "trace_id": "74337fb2-9b5e-46de-8855-e81c68ecc9e2"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-05-07"
  },
  "data": [
    {
      "id": 341,
      "type": "VariantTherapeuticResponseProposition",
      "predicate": "predictSensitivityTo",
      "biomarkers": [
        {
          "id": 142,
          "name": "MSI-L",
          "genes": [],
          "type": "CategoricalVariant",
          "extensions": [
            {
              "name": "biomarker_type",
              "value": "Microsatellite Stability"
            },
            {
              "name": "present",
              "value": true
            },
            {
              "name": "status",
              "value": "Microsatellite instability-low (MSI-L)"
            }
          ]
        }
      ],
      "subjectVariant": {},
      "conditionQualifier": {
        "id": 18,
        "conceptType": "Disease",
        "name": "Endometrial Carcinoma",
        "primaryCoding": {
          "id": "oncotree:UCEC",
          "code": "UCEC",
          "name": "Endometrial Carcinoma",
          "system": "https://oncotree.mskcc.org",
          "systemVersion": "oncotree_2021_11_02",
          "iris": [
            "https://oncotree.mskcc.org/?version=oncotree_2021_11_02&field=CODE&search=UCEC"
          ]
        },
        "mappings": []
      },
      "objectTherapeutic": {
        "id": 61,
        "membership_operator": "AND",
        "therapies": [
          {
            "id": 132,
            "conceptType": "Drug",
            "name": "Lenvatinib",
            "primaryCoding": {
              "id": "ncit:C95124",
              "code": "C95124",
              "name": "Lenvatinib",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C95124"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:1603296",
                  "code": "1603296",
                  "name": "lenvatinib",
                  "system": "RxNorm",
                  "systemVersion": "02-Mar-2026",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1603296"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:46221433",
                  "code": "46221433",
                  "name": "lenvatinib",
                  "system": "OMOP",
                  "systemVersion": "v20260227",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/46221433"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:714108002",
                  "code": "714108002",
                  "name": "Lenvatinib",
                  "system": "SNOMED",
                  "systemVersion": "2025-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=714108002&edition=MAIN/2025-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:37017773",
                  "code": "37017773",
                  "name": "Lenvatinib",
                  "system": "OMOP",
                  "systemVersion": "v20260227",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/37017773"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "VEGFR inhibition"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Targeted therapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          },
          {
            "id": 48,
            "conceptType": "Drug",
            "name": "Pembrolizumab",
            "primaryCoding": {
              "id": "ncit:C106432",
              "code": "C106432",
              "name": "Pembrolizumab",
              "system": "https://evsexplore.semantics.cancer.gov",
              "systemVersion": "25.01d",
              "iris": [
                "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C106432"
              ]
            },
            "mappings": [
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "rxcui:1547545",
                  "code": "1547545",
                  "name": "pembrolizumab",
                  "system": "RxNorm",
                  "systemVersion": "02-Mar-2026",
                  "iris": [
                    "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1547545"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:45775965",
                  "code": "45775965",
                  "name": "pembrolizumab",
                  "system": "OMOP",
                  "systemVersion": "v20260227",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/45775965"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "sctid:716125002",
                  "code": "716125002",
                  "name": "Pembrolizumab",
                  "system": "SNOMED",
                  "systemVersion": "2025-03-01",
                  "iris": [
                    "https://browser.ihtsdotools.org/?perspective=full&conceptId1=716125002&edition=MAIN/2025-03-01&release=&languages=en"
                  ]
                }
              },
              {
                "relation": "relatedMatch",
                "coding": {
                  "id": "omop:37396350",
                  "code": "37396350",
                  "name": "Pembrolizumab",
                  "system": "OMOP",
                  "systemVersion": "v20260227",
                  "iris": [
                    "https://athena.ohdsi.org/search-terms/terms/37396350"
                  ]
                }
              }
            ],
            "extensions": [
              {
                "name": "therapy_strategy",
                "value": [
                  "PD-1/PD-L1 inhibition"
                ],
                "description": "Associated therapeutic strategy or mechanism of action of the therapy."
              },
              {
                "name": "therapy_type",
                "value": "Immunotherapy",
                "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
              }
            ]
          }
        ]
      }
    }
  ]
}